{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:59:29Z","timestamp":1792511969963,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000261","name":"Multiple Sclerosis Society of Canada","doi-asserted-by":"publisher","award":["EGID 918124"],"award-info":[{"award-number":["EGID 918124"]}],"id":[{"id":"10.13039\/501100000261","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.msard.2025.106392","type":"journal-article","created":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T19:02:59Z","timestamp":1742756579000},"page":"106392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Comparison of vision-related quality of life in NMOSD and MOGAD"],"prefix":"10.1016","volume":"97","author":[{"given":"Adnan A.","family":"Gassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Konig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosane","family":"Nisenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Freedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesly","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth Ann","family":"Marrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"McCombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Micieli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie E.","family":"Parks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope","family":"Smyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7280-3684","authenticated-orcid":false,"given":"Dalia L.","family":"Rotstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2025.106392_bib0001","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000985","article-title":"Pain, depression, and quality of life in Neuromyelitis Optica Spectrum disorder: a cross-sectional study of 166 AQP4 antibody-seropositive patients","volume":"8","author":"Ayzenberg","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2025.106392_bib0002","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/brain\/awu335","article-title":"Vision and vision-related outcome measures in multiple sclerosis","volume":"138","author":"Balcer","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.msard.2025.106392_bib0003","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD Panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2025.106392_bib0004","doi-asserted-by":"crossref","first-page":"17545","DOI":"10.1038\/s41598-022-19848-4","article-title":"Structure-function correlates of vision loss in neuromyelitis optica spectrum disorders","volume":"12","author":"Gigengack","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.msard.2025.106392_bib0005","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001126","article-title":"Leveraging visual outcome measures to advance therapy development in neuroimmunologic disorders","volume":"9","author":"Graves","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2025.106392_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J. Biomed. Inform."},{"key":"10.1016\/j.msard.2025.106392_bib0007","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J. Biomed. Inform."},{"key":"10.1016\/j.msard.2025.106392_bib0008","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3389\/fneur.2020.00501","article-title":"Epidemiology of Neuromyelitis Optica spectrum disorder and its prevalence and incidence worldwide","volume":"11","author":"Hor","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2025.106392_bib0009","doi-asserted-by":"crossref","DOI":"10.1038\/s41433-024-03108-y","article-title":"MOG antibody-associated optic neuritis","author":"Jeyakumar","year":"2024","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.msard.2025.106392_bib0010","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2025.106392_bib0011","article-title":"Fatigue is a common symptom in myelin oligodendrocyte glycoprotein antibody disease","volume":"8","author":"Ladakis","year":"2022","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"10.1016\/j.msard.2025.106392_bib0012","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/jamaneurol.2020.3115","article-title":"Long-term outcomes in patients with myelin oligodendrocyte glycoprotein immunoglobulin G-Associated disorder","volume":"77","author":"Lopez-Chiriboga","year":"2020","journal-title":"JAMa Neurol."},{"key":"10.1016\/j.msard.2025.106392_bib0013","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/archopht.119.7.1050","article-title":"Development of the 25-item national eye institute visual function questionnaire","volume":"119","author":"Mangione","year":"2001","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.msard.2025.106392_bib0014","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1001\/archneurol.2012.314","article-title":"Epidemiology of neuromyelitis optica in the United States: a multicenter analysis","volume":"69","author":"Mealy","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.msard.2025.106392_bib0015","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s40120-022-00356-6","article-title":"Impact of Neuromyelitis Optica spectrum disorder on quality of life from the patients' Perspective: an observational cross-sectional study","volume":"11","author":"Meca-Lallana","year":"2022","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.msard.2025.106392_bib0016","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1136\/jnnp.2008.165449","article-title":"Vision related quality of life in multiple sclerosis: correlation with new measures of low and high contrast letter acuity","volume":"80","author":"Mowry","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2025.106392_bib0017","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.2147\/OPTH.S115159","article-title":"Assessment of quality of life in patients with visual impairments using a new visual function questionnaire: the VFQ-J11","volume":"10","author":"Nakano","year":"2016","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.msard.2025.106392_bib0018","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1212\/WNL.0000000000011153","article-title":"Worldwide incidence and prevalence of Neuromyelitis Optica: a systematic review","volume":"96","author":"Papp","year":"2021","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2025.106392_bib0019","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/jnnp-2017-316880","article-title":"Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination","volume":"89","author":"Ramanathan","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2025.106392_bib0020","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1167\/iovs.09-3766","article-title":"Reliability and validity of the National Eye Institute Visual Function Questionnaire-25 in patients with age-related macular degeneration","volume":"51","author":"Revicki","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.msard.2025.106392_bib0021","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.42780","article-title":"Factors associated with relapse and treatment of myelin oligodendrocyte glycoprotein antibody-associated disease in the United Kingdom","volume":"5","author":"Satukijchai","year":"2022","journal-title":"JAMa Netw. Open."},{"key":"10.1016\/j.msard.2025.106392_bib0022","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2377-14-31","article-title":"Relations of low contrast visual acuity, quality of life and multiple sclerosis functional composite: a cross-sectional analysis","volume":"14","author":"Schinzel","year":"2014","journal-title":"BMC. Neurol."},{"key":"10.1016\/j.msard.2025.106392_bib0023","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.msard.2016.11.008","article-title":"Severe structural and functional visual system damage leads to profound loss of vision-related quality of life in patients with neuromyelitis optica spectrum disorders","volume":"11","author":"Schmidt","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106392_bib0024","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1265170","article-title":"Association of aquaporin-4 antibody-seropositive optic neuritis with vision-related quality of life and depression","volume":"14","author":"Song","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2025.106392_bib0025","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1097\/IAE.0000000000001316","article-title":"Responsiveness of the national eye institute visual function questionnaire-25 to visual acuity gains in patients with diabetic macular edema: evidence from the RIDE and RISE trials","volume":"37","author":"Suner","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.msard.2025.106392_bib0026","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1167\/iovs.08-3225","article-title":"Responsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: validation studies from two phase 3 clinical trials","volume":"50","author":"Suner","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.msard.2025.106392_bib0027","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/bjo.2004.047498","article-title":"Impact of unilateral and bilateral vision loss on quality of life","volume":"89","author":"Vu","year":"2005","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.msard.2025.106392_bib0028","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825001348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825001348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T11:40:38Z","timestamp":1762602038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825001348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":28,"alternative-id":["S2211034825001348"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106392","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of vision-related quality of life in NMOSD and MOGAD","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106392","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106392"}}